LJLena Jelinek

Lena Jelinek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lena Jelinek has a total of 348 co-authors. Here are the top co-authors by number of shared publications:

  • Steffen Moritz

    Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    88 shared publications
  • Steffen Moritz

    Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    32 shared publications
  • Franziska Miegel

    Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany

    21 shared publications
  • Marit Hauschildt

    Department of Psychiatry and Psychotherapy University Medical Center Hamburg‐Eppendorf Hamburg Germany

    16 shared publications
  • Michael Kellner

    University Medical Center Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Martinistraße 52, 20246, Hamburg, Germany

    15 shared publications
  • Birgit Hottenrott

    University Medical Center Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Martinistr, 52, 20246 Hamburg, Germany

    14 shared publications

Latest Publications

  • Open Access

    Obsessive-Compulsive Symptoms During Pregnancy and the Postpartum Period: A Cross-Sectional Comparison with Non-Perinatal Female Controls During the COVID-19 Pandemic

    by Jana Christina Müller, Laura Michalke, Amir-Hosseyn Yassari, Franziska Miegel, Heiko Albrecht, Lena Jelinek

    Background : Pregnancy and the postpartum period have been associated with increased vulnerability to obsessive–compulsive symptoms (OCSs), while the COVID-19 pandemic introduced additional psychological stressors. This study compared self-reported OCSs, depressive symptoms, and anxiety symptoms among pregnant, postpartum, and non-perinatal female controls during the COVID-19 pandemic. Methods: In this cross-sectional online study, 203 women were assessed between June 27 and August 9, 2021, including 66 pregnant women, 53 women who had given birth within the preceding 12 months, and 84 non-perinatal female controls. Symptoms were assessed using the Obsessive–Compulsive Inventory—Revised (OCI-R), Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder-7 (GAD-7). The OCI-R recall period was modified to seven days, and its thresholds were used for exploratory categorization. Group differences were examined using analyses of variance and chi-square tests, supplemented by exploratory adjusted analyses. Results: Overall, 35.5% of participants scored at or above the exploratory OCI-R threshold of 18, while 30.2% and 21.3% scored at or above established screening thresholds for depressive and anxiety symptoms, respectively. The proportions did not differ significantly between groups for OCI-R ≥ 18 (p = 0.804), PHQ-9 ≥ 10 (p = 0.892), or GAD-7 ≥ 10 (p = 0.506). Continuous symptom scores also showed no statistically significant group differences. The proportion scoring at or above the exploratory OCI-R threshold of 28 was descriptively higher among postpartum women (22.6%) than among pregnant (10.6%) or non-perinatal female controls (9.5%), but the overall group comparison was not statistically significant (p = 0.065). Conclusions: No statistically significant differences in general self-reported OCSs, depressive symptoms, or anxiety symptoms were detected between pregnant, postpartum, and non-perinatal women. These findings do not establish equivalent symptom burden or exclude perinatal vulnerability to specific obsessive–compulsive symptoms. Larger longitudinal studies using validated perinatal-specific assessments are needed.

  • Shifting from Habituation to Intention: A Case Series of the Bergen 4-Day Treatment for Panic Disorder

    by Kim Juckoff, Amir H. Yassari, Jakob Scheunemann, Kay M. Hjelle, Bjarne Hansen, Lena Jelinek

  • Open Access

    Making Sense of Non-Response: What Patients Teach Us About Concentrated Exposure Therapy for Obsessive Compulsive Disorder

    by Lara Wille, Luisa Tegtmeier, Amir H. Yassari, Jakob Scheunemann, Silke Pawils, Franziska Miegel, Lena Jelinek

    Background/Objectives: The Bergen 4-Day Treatment (B4DT) is a concentrated form of exposure and response prevention for patients with obsessive–compulsive disorder (OCD). Although response rates for the B4DT are generally high, a proportion of patients does not achieve clinically significant improvements. Quantitative measures can identify non-response, but offer limited insight into processes that may hinder change in highly structured, time-limited interventions. To identify factors potentially related to the lack of improvement, this study explored experiences of patients who had not benefitted from B4DT. Methods: B4DT participants were recruited from an uncontrolled German study. Of 32 patients assessed at three-month follow-up, 12 met the non-response criteria (<35% reduction on the Yale–Brown Obsessive Compulsive Scale), and eight completed semi-structured qualitative interviews 9–14 months after treatment. Interviews were analyzed using grounded theory methods. A brief quantitative comparison examined baseline differences between responders and non-responders. Results: Participants described benefits from B4DT, including improved understanding of OCD, supportive peer contact, and increased courage for exposure tasks. However, they consistently reported difficulties sustaining self-guided exposure after treatment. Within the B4DT framework, one possible interpretation is that the intended shift toward independently approaching anxiety had not yet been fully consolidated. Conclusions: Although quantitatively classified as non-responders, participants described meaningful psychological benefits from B4DT. The findings suggest that non-response may reflect incomplete consolidation of the intended shift from symptom control toward approaching anxiety in service of personally meaningful action, rather than an absence of change.

  • Open Access

    Brief intervention, lasting impact: One-year outcomes of the Bergen 4-day treatment for OCD in Germany

    by Lena Jelinek, Amir H. Yassari, Saskia Pampuch, Franziska Miegel, Josephine Schultz, Bjarne Hansen, Kristen Hagen, Jürgen Gallinat, Jakob Scheunemann

    Background: Obsessive–compulsive disorder (OCD) is a prevalent and highly disabling mental disorder. Worldwide, it is associated with substantial individual suffering and long-term societal costs. Although exposure and response prevention (ERP) is the recommended first-line treatment, access to effective care remains limited for reasons such as long treatment duration. These barriers contribute to persistent global treatment gaps. The Bergen 4-Day Treatment (B4DT) is a brief, concentrated form of ERP (cERP) designed to improve treatment efficiency and access. Although initial outcomes are promising, long-term data from countries other than Norway are limited. This study evaluated the 12-month outcomes of the B4DT in a German day-patient treatment setting, exploring its sustained effectiveness and feasibility outside its original context. Methods: Fifty-eight adults with OCD received B4DT in an uncontrolled study and were reassessed 12 months after treatment. The primary outcome was OCD severity, assessed with the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Secondary outcomes included depressive symptoms, global functioning, self-efficacy, experiential avoidance, self-esteem, quality of life, and mental health service utilization. Results: Large reductions in OCD symptom severity (Y-BOCS) and significant improvements across most secondary outcomes were sustained at the 12-month follow-up. One year after treatment, 69% of participants met criteria for treatment response, 51% had achieved remission, and 78% showed reliable clinical improvement. No clinically relevant symptom deterioration was observed, and treatment acceptability and follow-up retention were high. Importantly, only a small proportion of patients ( n = 4; 7%) required inpatient treatment during the follow-up period. Conclusion: These findings demonstrate that brief cERP can achieve durable clinical benefits for patients with OCD when implemented outside its original context. From a global mental health and health policy perspective, the combination of short treatment duration, sustained effectiveness, and low subsequent use of inpatient services suggests that cERP represents a scalable and resource-efficient strategy to expand access to evidence-based OCD treatment across diverse health care systems.


  • Open Access

    Virtual Exposure With Response Prevention for Obsessive-Compulsive Disorder: Randomized Controlled Trial

    by Lara Rolvien, Lena Jelinek, Luzie Lohse, Steffen Moritz, Lisa Borgmann, Jürgen Gallinat, Simone Kühn, Franziska Miegel

    Background: Despite being highly effective and guideline-recommended for obsessive-compulsive disorder, exposure with response prevention is often underused due to barriers from both therapists and patients. Virtual reality may help address these barriers. Objective: This study aimed to assess the efficacy and acceptance of virtual exposure with response prevention (VERP) in patients with contamination obsessive-compulsive disorder (conOCD) and checking obsessive-compulsive disorder (checkOCD) and to identify factors influencing treatment success. Methods: Within a randomized controlled trial, 80 participants (40 with conOCD and 40 with checkOCD) were allocated to an intervention group, which received outpatient care as usual (CAU) supplemented by 6 weekly VERP sessions (VERP group), or to a control group receiving CAU alone (CAU group). Assessments occurred at baseline (t0), postintervention (t1), and at 3-month follow-up (t2). The reduction in obsessive-compulsive symptoms, as measured with the Yale-Brown Obsessive-Compulsive Scale, served as the primary outcome. Results: Overall, obsessive-compulsive symptoms showed no greater improvement in the VERP group compared to the CAU group from t0 to t1 or t2 (η p 2 =0.003-0.014). In exploratory subsample analyses, we observed a trend toward an interaction effect, showing greater reduction in obsessions among participants with checkOCD from t0 to t1 ( F 1,52 =3.91; P =.05; η p 2 =0.070) and greater anxiety reduction among participants with conOCD from t0 to t2 ( F 1,45 =4.11; P =.05; η p 2 =0.084). Exploratory moderation analysis suggested that adding VERP to CAU was more effective for those in the VERP group who had not prematurely discontinued prior psychological treatment and those with checking behavior. Sense of presence was only moderate, unrelated to outcome, and patient satisfaction with VERP was positive overall. Conclusions: While overall symptom reduction did not significantly differ between groups, exploratory analyses suggested trend-level differences in treatment response across obsessive-compulsive disorder subtypes and patient characteristics. These findings should be interpreted cautiously and are best viewed as hypothesis-generating.

  • Open Access

    Culturally adapted Metacognitive Training for Depression (CA-D-MCT) for Arabic- and Farsi-speaking refugees: a feasibility trial

    by Cornelia Uhr, Franka Metzner, Silke Pawils, Adekunle Adedeji, Mona Dietrichkeit, Lena Jelinek, Nexhmedin Morina

    Background: A significant number of people with a refugee background suffer from depression and may benefit from psychological interventions. Culturally adapted Metacognitive Training for Depression (CA-D-MCT) is a low-threshold and resource-saving group intervention that has not yet been evaluated among refugees with depression.Objective: This study aimed to assess the feasibility, patient acceptance, and initial treatment effects on depression and other secondary outcomes of CA-D-MCT for refugees with depression, potentially presenting with comorbid post-traumatic stress disorder (PTSD).Method: In an uncontrolled feasibility trial, 50 adult refugees with a diagnosis of depression, who spoke Arabic or Farsi, received interpreter-assisted CA-D-MCT. Patients completed module evaluations to assess acceptability. Depressive symptoms were assessed with the Patient Health Questionnaire (PHQ-9) at baseline (t0), post-treatment (t1) and at three-month follow-up (t2). Secondary outcomes included quality of life, subjective integration and PTSD symptoms.Results: Descriptive analysis showed a high level of acceptability of the intervention. A repeated-measure ANOVA revealed a large effect size associated with improvements in depressive symptoms (η² = .175, p = .010), suggesting a positive treatment effect. Medium effect sizes were observed for subjective integration, quality of life and PTSD symptoms, but differential values were not statistically significant.Conclusions: CA-D-MCT seems to be feasible and well accepted. The findings provide preliminary evidence for a treatment effect of CA-D-MCT. A randomized controlled trial is warranted to further investigate its efficacy.


  • Open Access

    Translation and validation of the German 12-item Obsessive-Compulsive Inventory (OCI-12) in clinical and non-clinical samples

    by Celina L. Müller, Jakob Fink-Lamotte, Lena Jelinek, Luzie Lohse, Thomas Ehring, Michael Noll-Hussong, Götz Berberich, Andreas Wahl-Kordon, Jens Borgelt, Dean McKay, et al.

    Background: The Obsessive-Compulsive Inventory-Revised (OCI-R) is widely used to assess symptoms of Obsessive-Compulsive Disorder (OCD). Despite its consistent factor structure, criticism on its syndromal validity has been raised. With the recent update of the commonly used diagnostic manuals, hoarding symptoms are now better captured by the diagnosis “pathological hoarding”. Furthermore, the neutralising scale suffers from relatively low psychometric properties. Consequently, a 12-item version of the scale (OCI-12), excluding hoarding and neutralising items was recently developed in English. The current study examined the psychometric properties of the German version of the OCI-12. Method: The psychometric properties of the translated German version of the OCI-12 were investigated in a German-speaking sample, consisting of 102 participants with OCD, 69 participants with an anxiety-related disorder, and 248 non-clinical controls. Results: The German version of the OCI-12 replicated the four-factor structure of the original English version, with a higher order factor of general OCD symptoms. In addition, similar to the original version, the German OCI-12 showed good internal consistency and test-retest reliability, moderate-to-good construct validity, and good-to-excellent diagnostic accuracy. Conclusion: The German version of the OCI-12 represents a syndromally valid and reliable inventory for assessing OCD symptoms. Psychometric properties are good-to-excellent and comparable to the original English version. The diagnostic sensitivity is good-to-excellent and further supports using the OCI-12 in clinical and research settings.